Prostatic Neoplasms: all 6,484 studies
Page 12 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate CancerRecruitingNCT05530655Early Phase 1
- BAseLine TEstosterone as a Prognostic and/or Predictive bioMARKer in mHSPCNot yet recruitingNCT05530395
- Investigation of Tumor Microenvironment After CRPC Along With Before and After Neoadjuvant Therapy for Prostate CancerNot yet recruitingNCT05522907
- EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&TRecruitingNCT05521412Phase 1/2
- 18F-PSMA-1007 PET/CT in Prostate Cancer - Access Trial 2022 to 2028RecruitingNCT05520255Phase 3
- Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary CancersRecruitingNCT05519878Not applicable
- Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)RecruitingNCT05519449Phase 1
- Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer PatientsRecruitingNCT05515978Early Phase 1
- Automatic Detection in MRI of Prostate Cancer: DAICAPRecruitingNCT05513820
- Artificial Intelligence-Based Computer-Aided Diagnosis of Prostate CancerRecruitingNCT05513638
- Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability TestingRecruitingNCT05497024
- Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic EvaluationRecruitingNCT05487846Not applicable
- Outcomes of Focal Ablation for Prostate CancerRecruitingNCT05478694
- Cleveland African American Prostate Cancer ProjectRecruitingNCT05469269Not applicable
- The Efficacy and Safety of Docetaxel Combined With Platinum for Metastatic Hormone-sensitive Prostate CancerRecruitingNCT05461261Phase 2
- [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and ApplicationRecruitingNCT05458544Phase 1/2
- An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate CancerRecruitingNCT05454488Phase 2
- Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate CancerRecruitingNCT05448547Phase 3
- Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer DetectionRecruitingNCT05443412
- MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate CancerRecruitingNCT05438563Not applicable
- Mechanisms of Resistance to PSMA Radioligand TherapyRecruitingNCT05435495
- Impact of Abdominal Incompetence on Urinary Incontinence After Prostatectomy (PROSTABDO)RecruitingNCT05432687Not applicable
- A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate CancerRecruitingNCT05430737Not applicable
- Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.RecruitingNCT05422911Phase 2
- Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid MalignanciesRecruitingNCT05417594Phase 1/2
- Anti-tumour Activity of (177Lu) rhPSMA-10.1 InjectionRecruitingNCT05413850Phase 1/2
- Study of ORIC-944 in Patients With Metastatic Prostate CancerRecruitingNCT05413421Phase 1
- Analyzing Clinical Trial Experiences of Prostate Cancer PatientsNot yet recruitingNCT05411354
- Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate CancerRecruitingNCT05406999Phase 2
- Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)RecruitingNCT05404139Phase 2
- Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)RecruitingNCT05403177
- Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand TherapyRecruitingNCT05398302Phase 1
- Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate CancerRecruitingNCT05396872Not applicable
- Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPCRecruitingNCT05393791Phase 2
- Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk CohortRecruitingNCT05384535Not applicable
- PSMA-PET to Guide ProstatectomyRecruitingNCT05381103Phase 2/3
- Addition of a Focal Boost in External Beam Radiotherapy for Locally Advanced Prostate Cancer by Online Adaptive MR-guided RadiotherapyNot yet recruitingNCT05373316Phase 2
- MRI-guided Focal Laser Ablation Prostate CancerRecruitingNCT05370482Not applicable
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseRecruitingNCT05366881
- A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation TherapyRecruitingNCT05361798Phase 2
- Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate CancerRecruitingNCT05354375Phase 1
- Metastasis-directed Therapy for Oligorecurrent Prostate CancerRecruitingNCT05352178Phase 3
- AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad OncRecruitingNCT05351424Not applicable
- A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)RecruitingNCT05348876Phase 4
- Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate CancerRecruitingNCT05346848Phase 2
- Observational Study on Extreme Hypofractionation for Localized Prostate CancerRecruitingNCT05344235
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRecruitingNCT05334069
- Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate CancerRecruitingNCT05328505Not applicable
- Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation TherapyRecruitingNCT05327465Not applicable
- 68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer PatientsRecruitingNCT05324332Not applicable
- Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate CancerRecruitingNCT05313815Not applicable
- Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated TumorsRecruitingNCT05313191Not applicable
- Tumor Microenvironment Analysis of Prostate Cancer MetastasisRecruitingNCT05304858
- Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate BiopsyRecruitingNCT05295407
- Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing TumorsRecruitingNCT05283330Phase 1
- Lymphedema After Urologic SurgeryRecruitingNCT05264337
- Efficacy and Safety of Darolutamide Combined With ADT in High-risk/Very High-risk Localized Prostate CancerRecruitingNCT05249712Phase 2
- MRI/Ultrasound Fusion Guided Laser Ablation of Prostate CancerRecruitingNCT05241236
- Early Salvage Therapy for Patients With Advanced Features for Biochemical Relapse After Radical Prostatectomy for Localized Prostate Carcinoma In Correlation With Supposed Molecular-genetic Parameters of Higher AggressivenessNot yet recruitingNCT05232578Phase 3
- TERPS Trial for de Novo Oligometastic Prostate CancerRecruitingNCT05223803Phase 2
- A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer SurvivorsRecruitingNCT05214937Not applicable
- START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPCRecruitingNCT05209243Not applicable
- Correlation Between Seminal Vesicle Size and Duration of Sexual AbstinenceRecruitingNCT05192252
- TherApeutics in Early ProState Cancer (TAPS02)RecruitingNCT05191680Phase 2
- LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New TechnologyRecruitingNCT05184790
- MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)RecruitingNCT05183074Not applicable
- Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical ProstatectomyRecruitingNCT05169112Phase 3
- Transperineal Laser Ablation Treatment (TPLA) for Prostate Cancer (PCa) RegistryRecruitingNCT05163197
- PSMA Response in Metastasized Hormone Sensitive Prostate CancerRecruitingNCT05161728Not applicable
- A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDGEnrolling by invitationNCT05160480
- Clinical Trial of Approaches to Prostate Cancer SurgeryRecruitingNCT05155501Not applicable
- Prostate Cancer Genetic Risk Evaluation and Screening StudyRecruitingNCT05129605
- Randomized Pilot Study of Radiosurgery for the Treatment of Non-metastatic Prostate CancerRecruitingNCT05123391Not applicable
- Circulating Tumor DNA (ctDNA) Monitoring in the Assessment and Prediction of the Efficacy of PARP Inhibitors (PARPi)RecruitingNCT05116579
- Evaluation of dAroLutamide Addition to anDrogen Deprivation Therapy and radIatioN Therapy in Newly Diagnosed Prostate Cancer With Pelvic Lymph Nodes MetastasesRecruitingNCT05116475Phase 3
- Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate CancerRecruitingNCT05113537Phase 1/2
- The Prognostic Role of Lymph Node Dissection In Men With Prostate Cancer Treated With Radical ProstatectomyRecruitingNCT05109910Not applicable
- Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes MetastasesRecruitingNCT05106699Not applicable
- First-in-human Study of OVM-200 as a Therapeutic Cancer VaccineRecruitingNCT05104515Phase 1
- To Live Better After Prostate Cancer Treatment:RecruitingNCT05100121Not applicable
- The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation.RecruitingNCT05097274
- Acupuncture Versus Sham Acupuncture or Usual Care for Antiandrogen-Induced Hot fLashes in Prostate Cancer (AVAIL)RecruitingNCT05069467Not applicable
- ONCOlogy-targeted NLP-powered Federated Hyper-archItecture and Data Sharing Framework for Health Data ReusabilityNot yet recruitingNCT05060835
- Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit MonitoringRecruitingNCT05054296Phase 2
- Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer PatientsRecruitingNCT05045066Early Phase 1
- Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)RecruitingNCT05043012Not applicable
- Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])RecruitingNCT05038332Phase 2
- Evaluating the Effectiveness of the Nurse Ned ClinicRecruitingNCT05033301Not applicable
- Can MRI of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a TumourRecruitingNCT05024162Not applicable
- PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHERecruitingNCT05022914
- Comparison of Diagnostic Accuracy of Luminal Index and MP MRI for Accelerated deTEction of Significant Prostate CancerRecruitingNCT05020522Not applicable
- SRT Versus SRT+ADT in Prostate CancerRecruitingNCT05019846Phase 3
- High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate CancersRecruitingNCT05011383Phase 2
- Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate CancerRecruitingNCT05010343Phase 2
- Customized TULSA-PRO Ablation RegistryRecruitingNCT05001477
- Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy PatientsRecruitingNCT05000827Not applicable
- Atezolizumab Plus Tivozanib in Immunologically Cold Tumor TypesRecruitingNCT05000294Phase 1/2
- An Evaluation of the Efficacy and Safety of Apalutamide as Neoadjuvant Endocrine Therapy in High-Risk and Oligometastatic Prostate CancerRecruitingNCT04997252Not applicable
- PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment EffectivenessRecruitingNCT04995198
- Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer With Combination of PSA/DRE and Multi Parametric Magnetic Resonance ImagingNot yet recruitingNCT04993508Not applicable